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Abstract 
Stroke is a major global health problem whereby many survivors have unmet needs concerning mobility 
during recovery. As such, the use of robotic assisted devices (i.e., a bionic leg) within a community-setting 
may be an important adjunct to normal physiotherapy in chronic stroke survivors. This study will be a dual-
centre, randomized, parallel group clinical trial to investigate the impact of a community based, training 
program using a bionic leg on biomechanical, cardiovascular and functional outcomes in stroke survivors. 
Following a baseline assessment which will assess gait, postural sway, vascular health (blood pressure, 
arterial stiffness) and functional outcomes (6-minute walk), participants will be randomized to a 10-week 
program group, incorporating either: i) physiotherapy plus community-based bionic leg training program, 
ii) physiotherapy only, or iii) usual care control. The training program will involve participants engaging 
in a minimum of 1 hour per day of bionic leg activities at home. Follow up assessment, identical to baseline, 
will occur after 10-weeks, 3 and 12 months post intervention. Given the practical implications of the study, 
the clinical significance of using the bionic leg will be assessed for each outcome variable. The potential 
improvements in gait, balance, vascular health and functional status may have a meaningful impact on 
patients’ quality of life. The integration of robotic devices within home-based rehabilitation programs may 
prove to be a cost effective, practical and beneficial resource for stroke survivors. 
 
Keywords: robotic assisted, stroke survivors, walking, gait, blood pressure 
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Introduction 
By 2030, stroke burden is expected to double, with increasing survival rates as medical care and 
treatment techniques improve (1). This leads to an increasing population with diverse stroke-related 
disabilities, which may include limitations in communication, activities of daily living, co-ordination, 
balance and mobility (2). It is estimated that following a stroke only 15% of sufferers will gain complete 
functional recovery for both the upper and lower extremities (3). As such, many stroke survivors continue 
to have unmet needs, especially concerning mobility (4). Although some individuals with stroke will have 
received some rehabilitation during the acute and sub-acute phases, rarely does rehabilitation extend beyond 
one year post-injury due to a lack of resources for long term services (5). 
Gait impairment, and therefore a reduction in functional ability, leads to many stroke survivors 
becoming sedentary. Objective activity monitoring of stroke survivors has showed that >80% of time is 
spent sedentary, independent of functional ability, and that in the first year post-stroke, there is minimal 
behavior change (6). With this increased sedentary time, there is a concurrent reduction in fitness and an 
increased risk of cardiovascular and all-cause mortality and morbidity (7). A reduction in post-stroke fitness 
could arise from the accumulation of low pre-stroke physical activity and fitness, direct neurological effects 
of stroke and the effect of post-stroke physical inactivity (8). For many stroke survivors, improving walking 
ability and mobility is widely regarded to be an important rehabilitation goal (9,10).  
Recent advances in medical technology have helped to develop robotic devices to aid gait training 
in order to restore pre-stroke movement patterns and improve quality of gait for stroke survivors (11). 
Robotic rehabilitation may help to promote limb function in stroke patients by stimulating neuroplasticity 
(12) and has the potential to provide intensive, repetitive, and task-specific practice which could enhance 
functional restitution and improve motor performances (13). Although some robotic devices are large, 
complex and cumbersome, which necessitates that the therapist be present during use (14), externally 
wearable commercially available devices that can be independently used during home-based post-stroke 
rehabilitation are available (15). The integration of robotic therapy into current practice could increase the 
efﬁciency and effectiveness of therapists by alleviating the labor-intensive aspects of physical rehabilitation 
and by enabling novel modes of exercise not currently available. Robotic-assisted gait training has been 
shown to exhibit significantly greater improvements in gait and balance, as measured by the functional 
ambulation capacity scale, when compared to regular physiotherapy alone (16). Furthermore, with 
significant increases in physical activity, step count, and walking capacity observed with the use of lower 
limb robotic devices (17), such applications may elicit important cardiovascular benefits for stroke 
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survivors (8). Increases in ambulatory activity has been shown to improve cardiorespiratory fitness and 
reduce the risk of recurrent cardiovascular events (18). 
Research into robotic devices has focused on the implementation within a clinical setting. As 
patient access to such devices may be constrained by both the accessibility and availability, community-
based programs may be efficacious as patients could use such devices more frequently. Despite this, to date, 
research into robotic devices within a community setting is limited for patients with stroke. Further, studies 
either have small (n = 1) sample sizes (19), or are non-randomized control trials (20). Accordingly, this 
study will investigate the acute and longer-term effects of using a lower limb robotic device in a community 
setting on pertinent biomechanical (gait, postural sway), vascular (blood pressure, arterial stiffness) and 
functional (lower limb strength, 6-minute shuttle walk test) measures in chronic stroke survivors. It is 
hypothesized that a 10-week community rehabilitation program with a robotic device (bionic leg) will lead 
to greater changes in the aforementioned outcome measures compared to stroke survivors receiving stand-
alone physiotherapy or usual care.  
 
Methods 
Research Design  
This is a dual-centre, randomized, parallel group clinical trial. Stroke survivors will be identified 
from a neuro-physiotherapy practice and/or community-based, stroke support groups (Figure 1). All 
participants will have been diagnosed with stroke by a specialist neurologist/stroke consultant from a UK 
National Health Service (NHS) Foundation Trust, and will have undertaken normal inpatient and outpatient 
rehabilitation in accordance with NICE guidelines (21). Participants with a Functional Ambulation Score 
of 2-5 (22), and who meet the following inclusion criteria are eligible to participate in the study. 
 
Inclusion criteria 
 Patients with diagnosis of stroke within 3 months to 5 years of study start date. 
 Community patients that are medically stable and are  either i) currently receiving physical therapy 
from a neurophysiotherapy practice, or ii) attending a community-based, stroke support group and 
do not actively receive physical therapy 
 Individuals who are able to stand and step with an aid or with assistance.  
 Cognitively aware to undertake rehabilitation exercises, physical therapy and physical activity   
 Height: 1.58 to 1.92 m 
 Weight: < 159 kg 
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Exclusion Criteria  
 Unresolved deep vein thrombosis, unstable cardiovascular conditions, open wounds, active drug 
resistant infection, recent fractures of involved limb, peripheral arterial disease, incontinence, 
severe osteoporosis, non-weight bearing. 
 
Randomization 
Web-based randomization procedures will be prepared by an investigator with no clinical 
involvement in the trial. Participants receiving physical therapy from the neurophysiotherapy practice will 
be assigned to one of two groups: 
i) a 10-week community-based, bionic leg plus normal physiotherapy program (BL) 
ii) a 10-week normal physiotherapy program (NP) 
 
A third group, recruited from community-based, stroke support groups, will also be assessed in the study: 
iii) Usual care case control group [no physiotherapy program] (CON) 
 
Covariate adaptive randomization is a valid randomization method for clinical research and will be 
used to ensure balance between BL and NP (23). Covariate adaptive randomization uses the method of 
minimization by assessing the imbalance of sample size between several covariates. In this study, 
participants will be sequentially assigned to BL or NP by taking into account the following specific 
covariates: i) baseline postural sway (only able to stand with an aid vs. able to stand unaided; able to stand 
≤ 2 mins vs. able to stand > 2 mins), ii) systolic blood pressure (SBP > 160 vs. < 160 mmHg), iii) age (age 
> 70 y vs. < 70 y), and iv) time since stroke (< 12 months vs. > 12 months). Allocation will be undertaken 
by the principle investigator, who will not be involved in assessing patient outcomes. The principal 
investigator will inform the participant of group allocation. Although participants and a research assistant 
will be aware of the allocated treatment condition, outcome assessors and data analysts will be kept blinded 
to the allocation, which will be concealed until the end of the study. 
 
Baseline assessment and outcome measures 
Participants will be fasted (> 10 hours), refrain from caffeine consumption for > 12 hours and will 
not have undertaken moderate-to-strenuous physical activity for > 24 hours prior to the baseline laboratory 
assessment. Primary and secondary outcome measures will be monitored during the baseline assessment 
(Figure 1, Table 1). These measures include biomechanical (gait analysis, postural sway), cardiovascular 
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(central and peripheral blood pressures, arterial stiffness of the carotid artery, blood velocity of the carotid 
artery) and functional (aerobic fitness, strength) tests. Cardiovascular measures will be completed first, in 
a supine position, following 20 minutes of supine rest (Figure 2). Biomechanical measures will be recorded 
whilst standing, and during walking-based movement assessments. Functional measures will be undertaken 
in both supine and upright seated positions (lower-limb strength tests) and during a physical ambulatory 
test (aerobic fitness test). On completion of the baseline health assessment participants will also complete 
a series of questionnaires including the International Physical Activity Questionnaire (IPAQ), Older 
People’s Quality of Life Questionnaire, Functional Ambulation Classification, Dynamic Gait Index, Berg 
Balance Scale and Trail Making Test (Table 1). Follow up assessments of all primary and secondary 
assessments will occur at 10-weeks post intervention, 3 and 12 months post.  
On completion of the baseline assessment participants will be randomized to either BL or NP, if 
identified from a neuro-physiotherapy practice, or will be identified from a local stroke support group and 
will contribute to the usual care control group. Participants will also wear an ActivPal (Glasgow, Scotland) 
to assess daily physical activity. The monitor will be secured onto the mid rectus femoris for a period of 7 
days following the baseline assessment, at 5 weeks mid-intervention, 10-weeks post intervention, 3 and 12 
months follow-up.  
 
Bionic leg group (BL) 
Participants randomized to the BL group will receive a bionic leg (Alter-G, Fremont, CA, USA) to 
take home for the duration of the study. Participants will be required to wear the bionic leg for a minimum 
of 1 hour per day, for a period of 10-weeks. Although recorded, no daily maximum wear-time will be 
imposed on participants. Settings for the bionic leg will be individualized for each participant, consisting 
of weight, assistance, resistance, threshold and knee extension angle settings. Participants’ progress with 
the bionic leg will be checked at weeks 2, 4, 6, and 8 by a research assistant. The assistance and threshold 
settings will be altered in an attempt to elicit progressive overload. Assistance refers to the amount of 
support the device provides to the participant to help with extension of the lower extremity. This is an 
approximate percentage of the individual’s single-limb bodyweight, whereby a higher value demonstrates 
a greater contribution from the bionic leg. Threshold refers to the percentage of overall body weight that is 
necessary through the participant’s foot to activate the device’s footplate before it will provide assistance. 
A lower value activates the device with less weight and is therefore more sensitive to small weight shifts 
making it easier for the participant. Participants will also be provided with a physical activity diary whereby 
the number of steps, duration of use and activities undertaken while using the bionic leg are recorded daily. 
During this time, participants will also undertake their regular rehabilitation therapy at their physiotherapy 
practice.  
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Normal physiotherapy group (NP) 
Participants will undertake their regular rehabilitation therapy at their local physiotherapy practice. 
Participants will also be advised to engage in a minimum of 1 hour of physical activity each day for the 
duration of the 10 week intervention.  
 
Usual care case control group (CON) 
Participants will be advised to engage in a minimum of 1 hour of physical activity each day for the 
duration of the 10-week intervention. These participants will not attend any rehabilitation sessions for the 
period of the intervention. 
 
Participants in both NP and CON will keep a record of their daily activity recording their total time 
active, and type of activities undertaken. 
 
Ethical approval and informed consent 
The study protocol has received institutional ethical approval. The study has also been registered 
with the Clinical Trials.gov Protocol Registration and Results System (NCT03104127). Written informed 
consent will be obtained from all participants prior to the commencement of the study.  
 
Data monitoring body 
A research steering committee will meet once every 3 months to discuss data and safety monitoring 
(i.e., adverse events) and to provide advice on implementation of the research outcomes and outputs. The 
steering committee will include members of the research team and external stakeholders from the university 
sector, rehabilitation practice and community. 
 
Sample size 
Forty-five participants will be recruited and evenly allocated to each of the three groups (BL, NP or CON) 
to enable an appropriate sample size to be calculated for a larger trial.   
 
Data analysis 
Baseline characteristics of the three study groups will be described by means and standard 
deviations and percentages as appropriate for the level of measurement and distributions of the data. 
Baseline characteristics will be compared between groups using a series of one-way analysis of variance 
(ANOVA). With the inclusion of the previously identified covariates (baseline postural sway, systolic blood 
pressure, age, time since stroke), a series of two-way repeated measures analysis of covariance: Condition 
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(BL, NP, CON) by Time (baseline, post-intervention, 3 & 12 month follow-up), will be used to compare 
all primary and secondary outcome measures. Where statistical differences are observed from the preceding 
analyses, post-hoc analyses for multiple comparisons will be conducted (Bonferroni adjusted t-tests; Tukeys 
HSD). An intention-to-treat analysis will be used on all consented participants who are unable to attend the 
follow-up assessment. Effect sizes will be reported to describe the importance of the relevant findings in 
practical terms using partial eta squared (ηp2), with 0.0099, 0.0588, and 0.1379 representing a small, 
medium, and large effect (24). 
 
Discussion  
With the worldwide burden of stroke expected to continue to rise, there is an ever increasing need 
to provide efficacious medical and rehabilitation treatment strategies. This is of great importance when 
considering that only a small proportion of stroke survivors regain complete functional recovery in the years 
following their stroke diagnosis (3). With stroke survivors often experiencing difficulties with walking, 
balance and mobility (9,10), lower-limb robotic devices, such as the bionic leg, may provide stroke 
survivors with the opportunity to improve everyday functional movements. Furthermore, as such devices 
may elicit an increase in physical activity by increasing the number of steps taken each day, there may be 
important cardiovascular and quality of life benefits for stroke survivors who engage with such technology 
during their rehabilitation as it may reduce the risk of future cardio- or cerebrovascular events. With 
physical therapists often using manual therapeutic approaches to improve upper and lower limb function 
during face-to-face rehabilitation sessions, the integration of robotic devices within home-based 
rehabilitation programs may elicit greater improvements in stroke survivors functional health (2,15).  Due 
to the increasing emphasis on moving stroke rehabilitation resources to community-based settings (25), and 
the overall lack of community-based stroke-rehabilitation research (26,27), there is a need to undertake 
randomized controlled trials within the community setting to evaluate the importance of using robotic 
devices.   
This study will significantly contribute to our knowledge in using lower-limb robotic devices in a 
community-based setting for patients with stroke. The potential improvements in gait, walking speed and 
balance may have a meaningful impact on patients’ everyday quality of life. As such, the use of a bionic 
leg within a community-setting may be an important adjunct to normal physiotherapy in chronic stroke 
survivors. The study will provide much needed data for stroke patients concerning the biomechanical and 
physiological effects of training programs incorporating robotic assistive devices. Given the practical 
implications of the study, the clinical significance of utilising the bionic leg in a 10-week training program 
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will be assessed for each outcome variable, over both the short- (baseline to post-intervention) and longer-
term (3 and 12 month post). 
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Table Legend: 
Table 1 Study outcomes to be measured at baseline, post-intervention, 3-months, and 12-months follow up 
 
Figure Legends: 
Figure 1 Study protocol 
Figure 2 Assessment procedure for baseline, post-intervention, 3 and 12 month follow-up 
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Table 1 Study outcomes to be measured at baseline, post-intervention, 3-months, and 12-months follow up 
Dependent variable Procedure / measures Study outcome Type of measurement 
BIOMECHANICAL    
Gait analysis Eight Qualisys cameras (six Oqus 3+, two Oqus 5+, Goteborg, Sweden) will be used to 
measure joint angles, rotations, hip obliquity, segment accelerations and velocities. Six 
Degrees or Fredom 6DoF 27 point marker set will be used and joint centres identified through 
palpation. The participants will be asked to walk for 6 meters, over a pressure mat (RSscan 
Footscan, Ipswitch, UK), for minimum of three trials in order to obtain walking gait patterns. 
A BTS G-Walk (Brooklyn, New York) sensor will also be worn by the participants to collect 
additional spatio-temporal gait parameters (cadence, speed, stride/step length, stance/swing 
phase duration, single/double support duration and pelvic girdle angles). 
 
Primary Movement Assessment 
Postural sway Postural sway parameters of maximal anterior-posterior and medio-lateral sway will be 
calculated on the basis of centre of pressure. Time series will be acquired by means of a 
pressure mat mounted on top of a Kistler force platform (Kistler, Winterthur, Swizerland). 
Participants will stand on the pressure mat, unaided if possible, and trials will consist of eyes 
open shoes on, eyes closed shoes on, eyes open shoes off, eyes closed shoes off. A minimum 
of three trials will be performed for each condition, each lasting 10s.  
 
Primary Balance 
    
Ashworth scale An adapted Modified Ashworth Scale will be used to assess muscle function. This will include 
the assessment of; Hip flexion, extension, abduction, adduction; Knee flexion, extension; 
Ankle dorsiflexion, plantar flexion. Each movement will be graded from 0-5. 
 
Secondary Resistance 
PHYSIOLOGICAL    
Health History Questionnaire Questionnaire to identify family history, personal history and signs and symptoms of 
cardiovascular disease, and to provide a lifestyle evaluation 
 
Secondary Rest 
Body mass  Body weight, body mass index 
 
     Secondary Rest 
Central and peripheral blood 
pressures 
Pulse wave analysis (PWA) will investigate central blood pressures, augmentation index and 
arterial stiffness following 20 minutes supine rest. Pulse wave velocity (PWV) will also be 
recorded between the carotid (right and left) and femoral artery, and between the anterior tibial 
artery (right and left) and femoral artery 
     Secondary Rest 
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Arterial stiffness of carotid artery Following 20 minutes supine rest, local arterial stiffness of the right and left carotid arteries 
will be imaged 1-2 cm proximal to the bifurcation using B-mode ultrasound.  
 
Secondary Rest 
Blood velocity of carotid artery 
 
 
 
FUNCTIONAL 
Doppler ultrasonography will be used to calculate bilaterally volumetric blood flow in the 
carotid artery. Blood flow will be recorded using a Doppler spectral trace for 1 minute during 
supine rest. 
 
Secondary Rest 
Physical fitness 
A 6-minute shuttle walk test will determine total distance walked. Participants’ perception of 
exertion will be measured at 2, 4 and 6 minutes.  
 
Secondary Physical activity 
Timed up-and-go A BTS G-walk system will be used to collect Timed-Up-and-Go data. From a seated position, 
participants will stand, walk to a cone 3 m away, walk around the cone, and walk back to the 
chair sit back down. Participants will complete two familiarisation trials prior to the actual 
test itself. A minimum of three trials will be performed. 
 
 
Secondary 
 
Physical activity 
Strength 
 
 
 
7-day physical activity 
 
 
 
QUESTIONNAIRES 
Dynamic gait index 
 
 
 
Lower Limb muscle strength will be assessed using a Lafayette hand held dynamometer 
(Lafayette, USA). Measures will include; Hip abduction, adduction, flexion; Knee flexion, 
extension; Ankle dorsiflexion, plantar flexion. Participants will be on a massage bed and 
perform up to three maximal trials for each measure with a minimum of one minutes rest 
between each measure. 
 
An ActivPal physical activity monitor will be used for 7 days at baseline, 5 weeks into the 
intervention, and on completion of the 10 week intervention to assess participants’ daily 
physical activity. Measures include; time seated, time standing, ambulation, number of steps, 
number of sit to stands, and energy expenditure. 
 
 
 
8-item test that assesses dynamic balance and gait ability. Scored by rating the participants’ 
performance; walking on a level surface, changing speed while walking, turning the head from 
side to side and up and down while walking, sudden turns, obstacle negotiation, and stair 
negotiation. The dynamic gate index has excellent reliability (ICC > 0.94) (28) and validity (r 
= 0.83) (29).  
 
Secondary 
 
 
 
 
Secondary 
 
 
 
 
 
 
 
Secondary 
 
Resistance 
 
 
 
 
Physical activity 
 
 
 
 
 
 
 
Physiotherapist assessment 
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Berg Balance 
 
 
 
Balance Confidence Scale 
 
 
Walking Ability Questionnaire 
 
 
Functional Ambulation 
Classification 
 
 
IPAQ 
 
 
Older Peoples Quality of Life 
Questionnaire 
 
Trail Making  
 
 
Stroop task 
14-item test that assesses static and dynamic balance ability and fall risk in adult populations. 
Each activity is scored from 0-4, determined by the ability to perform the assessed activity 
with an overall maximum score of 56. The Berg Balance scale has excellent reliability (ICC 
> 0.95) and strong correlations with the Fugl-Meyer and Postural Assessment Scale for Stroke 
patients (r > 0.90) (30). 
 
16-item self-report measure in which patients rate their balance confidence when performing 
various ambulatory activities. Rated from 0-100. This scale has excellent test-retest reliability 
(ICC = 0.85) within the Stroke population (31). 
 
19-item questionnaire to assess the participant’s social limitations resulting from decreased 
walking ability. Mobility is classified as independent, supervised, assisted, wheelchair or 
unable for 19 ambulatory activities commonly performed in the home and community. 
 
Assesses functional ambulation in participants undergoing physical therapy. Ranges from 
non-functional walking to independent walking outside with a scale for 0-5 respectively. The 
Functional Ambulation Classification has excellent validity with the 6 minute walking test in 
acute Stroke patients (32). 
 
 
Collects information on the time spent (number of days and average time per day) spent being 
physically active (33). 
 
 
36-item questionnaire that assesses quality of life. Each question is rated from 0-5 from very 
bad to very good respectively. The OPQLQ has excellent test-retest reliability (ICC = 0.92)  
(34) 
 
A neuropsychological test of visual attention and task switching. Consists of two tests, 
including: i) a test in which the participant is instructed to connect 25 numerical dots in order, 
and ii) a test in which the participant is instructed to connect 25 numerical and alphabetical 
dots in order. 
 
Is a measure of prefrontal cortex function (35) 
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# Identical to the baseline assessment 
Figure 1 Study protocol 
Stroke Diagnosis 
Attends neuro-physiotherapy practice and 
receives weekly physiotherapy / Attends stroke 
support group but does not receive 
physiotherapy 
 
Patient Screening: Inclusion criteria met 
Informed Consent provided 
Baseline Assessment (Table 1/Figure 2) 
No 
12 Month Follow-up Assessment # 
Randomization to either Bionic Leg* or Normal 
Therapy 
 
 
 
10 week Post-intervention Assessment # 
3 Month Follow-up Assessment # 
Excluded from research 
study 
No 
*Participants in the Bionic leg group 
will have the settings of the device 
checked at weeks 2, 4, 6 and 8 to 
ensure progressive overload 
 
 
Attends neuro-physiotherapy practice and 
receives weekly physiotherapy 
Attends stroke support 
group but does not receive 
physiotherapy (Control) 
 
No 
Yes 
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Abbreviations: BP = Blood pressure, CA = Carotid artery 
Figure 2 Assessment procedure for baseline, post-intervention, 3 and 12 month follow-up
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Physiological 
Health History 
Questionnaire 
Body Composition 
Central & peripheral BP 
Arterial stiffness of CA 
Blood velocity of CA 
Biomechanical Functional 
Gait Analysis 
Postural sway 
Ashworth Scale 
6-minute walk test 
Timed up and go 
Strength measures 
20 Minutes 20 minutes 60 minutes 30 minutes 
20 minutes supine rest 
7-Day 
ActivPal  
 
Participants to attend 
physiotherapy practice 
within 7 days of baseline 
tests for Questionnaires 
with a physiotherapist 
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